MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2022 International Congress

    ‘A study of seven patients with Hemimasticatory spasm; barriers to treatment and outcomes of botulinum toxin’

    A. Aundhakar, A. Nanavati, B. Mishal, P. Wadia (Mumbai, India)

    Objective: To assess barriers to treatment and outcomes of botulinum toxin in patients treated for Hemimasticatory spasm Background: Hemimasticatory spasm (HMS) is a rare peripherally induced…
  • 2022 International Congress

    IncobotulinumtoxinA for treating chronic sialorrhea due to Parkinson’s disease and other neurological conditions

    W. Jost, F. Pagan (Wolfach, Germany)

    Objective: To summarize clinical experience with incobotulinumtoxinA (INCO) for treating chronic sialorrhea due to Parkinson’s disease (PD), atypical parkinsonism, stroke, or traumatic brain injury in…
  • 2022 International Congress

    Successful treatment of Stiff Person Syndrome with botulinum toxin

    A. Gonçalves, F. Brunet, D. Ariton, O. de Fabregues (Loures, Portugal)

    Objective: Describe a case of Stiff Person Syndrome (SPS) treated with botulinum toxin injection and alert to the utility of botulinum toxin in this disorder.…
  • MDS Virtual Congress 2021

    Efficacy of Incobotulinumtoxin/A Treatment for Children/Adolescents with Sialorrhea associated with Neurological Disorders

    S. Berweck, H. Kim, M. Banach, A. Hanschmann, M. Althaus, M. Bonikowski (Vogtareuth, Germany)

    Objective: The SIPEXI (Sialorrhea Pediatric Xeomin Investigation) study investigated efficacy and safety of intraglandular incobotulinumtoxinA (incoBoNT/A) injections in children/adolescents with sialorrhea associated with neurological disorders…
  • MDS Virtual Congress 2021

    Botulinum toxin injections for sialorrhea in Parkinson´s disease and parkinsonism: 5 years follow up

    C. Borrue, C. Jimeno (Madrid, Spain)

    Objective: Investigate the safety and efficacy of botulinum toxin type A in Parkinson´s disease and parkinsonism patients affected by sialorrhea Background: Sialorrhea is excessive salivation…
  • MDS Virtual Congress 2020

    Pregnancy Outcomes Following Exposure to OnabotulinumtoxinA Update – 29 Years of Safety Observation

    M. Brin, A. Adams, L. Parker, A. Ukah, L. Radulian, L. Yedigarova, I. Yushmanova (Irvine, CA, USA)

    Objective: The present study evaluated pregnancy outcomes following onabotulinumtoxinA exposure to provide a cumulative 29-year safety update. Background: A previous publication of pregnancy outcomes in…
  • MDS Virtual Congress 2020

    Therapeutic effect of OnabotulinumtoxinA in bilateral hemifacial spasm, trigeminal neuralgia and chronic migraine in El Salvador

    J. Lopez-Castellanos, J. Lopez Contreras (Little Rock, AR, USA)

    Objective: To Evaluate the therapeutic and preventive effect of OnabotulinumtoxinA in the treatment of trigeminal neuralgia (TN) and chronic migraine (CM) in patients with bilateral…
  • MDS Virtual Congress 2020

    IncobotulinumtoxinA to treat sialorrhea in Parkinson’s disease: A real-life study

    B. Bergmans, V. Schotte, N. Sys, E. Van Massenhove, M. Van Zandijcke (Brugge, Belgium)

    Objective: We evaluate the long-term efficacy and safety of incobotulinumtoxinA injections in advanced Parkinson’s disease (PD) patients suffering from sialorrhea (10 injection cycles into the…
  • MDS Virtual Congress 2020

    Refining Knowledge on the Treatment of Pisa Syndrome with Botulinum Toxin

    C.A Artusi, F. Marchet, U. Dimanico, C. Zanella, M. Zibetti, A. Merola, G. Massazza, L. Lopiano (Torino, Italy)

    Objective: To analyze the efficacy of botulinum toxin (BoNT) in cases of pisa syndrome (PS) associated with Parkinson's disease (PD) targeting paraspinal muscles ipsilateral to…
  • MDS Virtual Congress 2020

    Effectiveness of onabotulinumtoxinA on reduction of rest tremor in Parkinson’s disease: A pilot study

    D. Roque, D. Drazheva, N. Browner, M. Sklerov, M. Collins (Chapel Hill, NC, USA)

    Objective: To determine the feasibility of a prospective study design aimed specifically at comparing the effect of onabotulinumtoxinA (BOT-A) to placebo injections on persons with…
  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 15
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley